Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Electroconvulsive Therapy01:30

Electroconvulsive Therapy

1.7K
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
1.7K
Psychosurgery01:30

Psychosurgery

2.2K
Psychosurgery, the surgical alteration or permanent removal of brain tissue to alleviate severe psychological conditions, stands as one of the most radical and controversial treatments in the history of mental health care. Its development and application have evolved significantly, marked by dramatic shifts in scientific understanding and ethical perspectives.
Historical Development of Psychosurgery
In the 1930s, Portuguese neurologist Antonio Egas Moniz introduced a surgical procedure designed...
2.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

880
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
880

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Establishing Quality Measures for the Prehospital Pediatric Readiness Project.

Prehospital emergency care·2026
Same author

Prehospital needle thoracostomy and the need to implement objective criteria for intervention: A retrospective study.

Injury·2025
Same author

Methods to establish a Pregnancy Register in the QResearch Database.

Communications medicine·2025
Same author

Rivaroxaban in Peripheral Artery Disease After Revascularization: Worst Events and Net Outcomes in VOYAGER PAD.

Journal of the American Heart Association·2025
Same author

Blood Pressure Lowering and Risk of Cancer: Individual Participant-Level Data Meta-Analysis and Mendelian Randomization Studies.

JACC. CardioOncology·2025
Same author

Author Correction: Safety outcomes following COVID-19 vaccination and infection in 5.1 million children in England.

Nature communications·2024

Related Experiment Video

Updated: Mar 10, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

10.6K

A Further Decrease in the Rates of Administration of Electroconvulsive Therapy in England.

Nicky Buley1, Emma Copland, Sophie Hodge

  • 1From the *Centre for Quality Improvement, Royal College of Psychiatrists, London; and †Oxford Health NHS Foundation Trust, Oxford, United Kingdom.

The Journal of ECT
|December 9, 2016
PubMed
Summary

Electroconvulsive therapy (ECT) use in England continues to decline, despite its effectiveness for major depression. This study tracked ECT frequency, patient demographics, and outcomes between 2012 and 2015, finding decreased prescription rates.

More Related Videos

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.7K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

686

Related Experiment Videos

Last Updated: Mar 10, 2026

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy
04:51

Pupillary Response as Assessment of Effective Seizure Induction by Electroconvulsive Therapy

Published on: April 11, 2019

10.6K
Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
09:07

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins

Published on: August 15, 2017

12.7K
Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol
10:54

Conventional Repetitive Transcranial Magnetic Stimulation for Depression: A Step-by-Step Protocol

Published on: November 21, 2025

686

Area of Science:

  • Psychiatry
  • Neurology
  • Clinical Medicine

Background:

  • Electroconvulsive therapy (ECT) is an effective treatment for major depression.
  • Despite improvements in ECT administration, studies indicate a decline in its use in the UK and Ireland.
  • There has been a lack of consistent data on ECT utilization and patient profiles for over two decades.

Purpose of the Study:

  • To estimate changes in the frequency of ECT use.
  • To analyze trends in ECT course length, patient demographics, and clinical outcomes.
  • To compare ECT utilization between 2006 and the periods of 2012/2013 and 2014/2015.

Main Methods:

  • Online surveys were administered to clinics to collect data on patients starting ECT.
  • Data collection focused on specific 12-month periods: April 1, 2012, to March 31, 2013, and April 1, 2014, to March 31, 2015.
  • The study analyzed patient demographics, course length, and clinical effectiveness.

Main Results:

  • A significant decline in the number of prescribed ECT courses was observed.
  • The average length of ECT courses has increased.
  • Women were twice as likely to receive ECT as men, with the modal age group being 60-80 years; depression was the most common diagnosis.
  • Most ECT courses were deemed clinically effective, particularly for severe illnesses.
  • Maintenance ECT was utilized in half of the surveyed clinics.

Conclusions:

  • The utilization of ECT in England shows a continuing downward trend.
  • The underlying reasons for this decline require further investigation.